Related Experiment Video
Updated: Aug 10, 2025

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Transcriptome-Based Traits of Radioresistant Sublines of Non-Small Cell Lung Cancer Cells
Margarita Pustovalova1, Philipp Malakhov1, Anastasia Guryanova1
1School of Biological and Medical Physics, Moscow Institute of Physics and Technology, 141700 Dolgoprudny, Russia.
Abstract:
Radioresistance is a major obstacle for the successful therapy of many cancers, including non-small cell lung cancer (NSCLC). To elucidate the mechanism of radioresistance of NSCLC cells and to identify key molecules conferring radioresistance, the radioresistant subclones of p53 wild-type A549 and p53-deficient H1299 cell cultures were established. The transcriptional changes between parental and radioresistant NSCLC cells were investigated by RNA-seq. In total, expression levels of 36,596 genes were measured. Changes in the activation of intracellular molecular pathways of cells surviving irradiation relative to parental cells were quantified using the Oncobox bioinformatics platform. Following 30 rounds of 2 Gy irradiation, a total of 322 genes were differentially expressed between p53 wild-type radioresistant A549IR and parental A549 cells. For the p53-deficient (H1299) NSCLC cells, the parental and irradiated populations differed in the expression of 1628 genes and 1616 pathways. The expression of genes associated with radioresistance reflects the complex biological processes involved in clinical cancer cell eradication and might serve as a potential biomarker and therapeutic target for NSCLC treatment.
Insights
This study explored how non-small cell lung cancer (NSCLC) cells become resistant to radiation therapy. Researchers identified specific gene expression changes that may offer new therapeutic targets for improving NSCLC treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Radioresistance presents a significant challenge in treating non-small cell lung cancer (NSCLC).
- Understanding the molecular mechanisms underlying NSCLC radioresistance is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the transcriptional alterations in radioresistant NSCLC cells.
- To identify key genes and molecular pathways associated with radioresistance in NSCLC.
- To establish radioresistant subclones of NSCLC cell lines for further study.
Main Methods:
- Establishment of radioresistant subclones from p53 wild-type (A549) and p53-deficient (H1299) NSCLC cell lines.
- RNA sequencing (RNA-seq) to analyze global gene expression changes.
- Utilizing the Oncobox bioinformatics platform to quantify pathway activation differences.
Main Results:
- In p53 wild-type A549 cells, 322 genes were differentially expressed after irradiation.
- In p53-deficient H1299 cells, 1628 genes and 1616 pathways showed altered expression post-irradiation.
- Significant transcriptional reprogramming occurs in NSCLC cells upon development of radioresistance.
Conclusions:
- Gene expression patterns in radioresistant NSCLC cells reflect complex biological processes.
- Identified genes and pathways may serve as potential biomarkers for NSCLC radioresistance.
- These findings suggest novel therapeutic targets for overcoming radioresistance in NSCLC treatment.
Related Concept Videos
Treatment Resistant Cancers
Non-LTR Retrotransposons
lncRNA - Long Non-coding RNAs

